Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis - PubMed (original) (raw)
doi: 10.1038/ki.2009.136. Epub 2009 Apr 29.
Affiliations
- PMID: 19404274
- DOI: 10.1038/ki.2009.136
Free article
Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis
Feng Yu et al. Kidney Int. 2009 Aug.
Free article
Abstract
There are few clinicopathologic and outcome data on patients with crescentic lupus nephritis, therefore, we determined factors of the disease by retrospectively reviewing the records of 327 patients diagnosed with lupus nephritis. Of these, 152 cases were regrouped as class IV-G, including 33 patients with crescentic glomerulonephritis. Significantly, all patients with crescentic glomerulonephritis had acute kidney injury as compared with only about a quarter of the patients without the disease. On pathological evaluation, activity scores, chronicity indexes, relapse rates, and the frequency of positive serum anti-neutrophil cytoplasmic antibody (ANCA) were each significantly higher, whereas complete remission rates and renal outcomes, over a mean follow-up of 4 years, were significantly poorer in patients with crescentic glomerulonephritis. Our study shows that crescentic glomerulonephritis was not rare in patients with lupus nephritis and that their long-term outcome was poor. The precise role of ANCA in the pathologic course of crescentic lupus nephritis remains to be determined.
Similar articles
- Serum antineutrophil cytoplasmic antibody positivity at the time of renal biopsy is associated with disease activity of lupus nephritis.
Zhang J, Lian R, Chen Y, Wan J. Zhang J, et al. Ren Fail. 2024 Dec;46(2):2357743. doi: 10.1080/0886022X.2024.2357743. Epub 2024 Jun 7. Ren Fail. 2024. PMID: 38847502 Free PMC article. - Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity.
Nasr SH, D'Agati VD, Park HR, Sterman PL, Goyzueta JD, Dressler RM, Hazlett SM, Pursell RN, Caputo C, Markowitz GS. Nasr SH, et al. Clin J Am Soc Nephrol. 2008 May;3(3):682-90. doi: 10.2215/CJN.04391007. Epub 2008 Feb 20. Clin J Am Soc Nephrol. 2008. PMID: 18287252 Free PMC article. - Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study.
Li C, Zhou ML, Liang DD, Wang JJ, Yang J, Zeng CH, Liu ZH, Zhang HT. Li C, et al. BMJ Open. 2017 Jul 28;7(7):e015668. doi: 10.1136/bmjopen-2016-015668. BMJ Open. 2017. PMID: 28756384 Free PMC article. - Membranous lupus nephritis with antineutrophil cytoplasmic antibody-associated segmental necrotizing and crescentic glomerulonephritis.
Marshall S, Dressler R, D'Agati V. Marshall S, et al. Am J Kidney Dis. 1997 Jan;29(1):119-24. doi: 10.1016/s0272-6386(97)90018-4. Am J Kidney Dis. 1997. PMID: 9002540 Review. - Immunosuppressive treatment for proliferative lupus nephritis.
Tunnicliffe DJ, Palmer SC, Henderson L, Masson P, Craig JC, Tong A, Singh-Grewal D, Flanc RS, Roberts MA, Webster AC, Strippoli GF. Tunnicliffe DJ, et al. Cochrane Database Syst Rev. 2018 Jun 29;6(6):CD002922. doi: 10.1002/14651858.CD002922.pub4. Cochrane Database Syst Rev. 2018. PMID: 29957821 Free PMC article. Review.
Cited by
- Serum antineutrophil cytoplasmic antibody positivity at the time of renal biopsy is associated with disease activity of lupus nephritis.
Zhang J, Lian R, Chen Y, Wan J. Zhang J, et al. Ren Fail. 2024 Dec;46(2):2357743. doi: 10.1080/0886022X.2024.2357743. Epub 2024 Jun 7. Ren Fail. 2024. PMID: 38847502 Free PMC article. - Renal involvement in systemic lupus erythematosus: additional histopathological lesions.
Muniz MPR, Brito LPAF, Vale PHC, Guedes FL, Oliveira TKM, de Araújo Brito DJ, Filho NS, Dantas M, Silva GEB. Muniz MPR, et al. Arch Med Sci. 2020 Jun 23;19(5):1398-1409. doi: 10.5114/aoms.2020.96617. eCollection 2023. Arch Med Sci. 2020. PMID: 37732045 Free PMC article. - Efficacy and Safety of Belimumab in Lupus Nephritis Patients: A Real-World Observational Study in China.
Tan M, Xu J, Tan Y, Qu Z, Yu F, Zhao M. Tan M, et al. Kidney Dis (Basel). 2023 Feb 14;9(3):218-228. doi: 10.1159/000529675. eCollection 2023 May. Kidney Dis (Basel). 2023. PMID: 37497208 Free PMC article. - Predictors of treatment outcomes in lupus nephritis with severe acute kidney injury and requirement of dialytic support.
Márquez-Macedo SE, Perez-Arias AA, Pena-Vizcarra ÓR, Zavala-Miranda MF, Juárez-Cuevas B, Navarro-Gerrard MA, Morales-Buenrostro LE, Mejía-Vilet JM. Márquez-Macedo SE, et al. Clin Rheumatol. 2023 Aug;42(8):2115-2123. doi: 10.1007/s10067-023-06629-1. Epub 2023 May 16. Clin Rheumatol. 2023. PMID: 37188962 - Outcomes and risk factors in patients with crescentic glomerulonephritis: a multicenter cohort study.
Su X, Song R, Li S, Guo W, Guo X, Qiao X, Wang L. Su X, et al. J Nephrol. 2023 May;36(4):1027-1035. doi: 10.1007/s40620-022-01550-3. Epub 2023 Feb 14. J Nephrol. 2023. PMID: 36786975
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources